Showing results (31-40 of 738) with videos related to
Sort By:
Pageof 74
Current Molecular Medicine|February 10, 2009
Atypical chemokine receptors in inflammatory diseaseManish Patel, Iain B McInnes, Gerard GrahamClinical and Experimental Rheumatology|February 15, 2013
Understanding the patient perspective - results of the Rheumatoid Arthritis: Insights, Strategies & Expectations (RAISE) patient needs surveyIain B McInnes, Bernard Combe, Gerd BurmesterClinical Rheumatology|June 6, 2024
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 studyChristopher T Ritchlin, Philip J Mease, Wolf-Henning Boehncke, et al.Current Opinion in Rheumatology|May 16, 2020
The IL-23/IL-17A axis in spondyloarthritis: therapeutics informing pathogenesis?Stefan Siebert, Andrew McGucken, Iain B McInnesCurrent Rheumatology Reports|February 27, 2014
The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatmentMarina Frleta, Stefan Siebert, Iain B McInnesExpert Opinion on Biological Therapy|December 8, 2006
Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditionsMichele Bombardieri, Iain B McInnes, Costantino PitzalisAnnals of the Rheumatic Diseases|February 2, 2012
Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidenceHanna Johnsson, Iain B McInnes, Naveed SattarACR Open Rheumatology|October 4, 2024
Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Year, Phase 3, Randomized, Controlled StudyPhilip J Mease, Xenofon Baraliakos, Vinod Chandran, et al.Immunology Letters|July 6, 2004
ES-62, a filarial nematode-derived immunomodulator with anti-inflammatory potentialWilliam Harnett, Iain B McInnes, Margaret M HarnettAnnual Review of Medicine|November 14, 2015
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated DiseasesGeorge E Fragoulis, Stefan Siebert, Iain B McInnesPageof 74